Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic
1 other identifier
interventional
80
1 country
1
Brief Summary
This single blind, randomized, controlled trial (RCT) evaluates, a nonpharmacological intervention, TM (Transcendental Meditation) for improving burnout (, as measured by self-reporting (survey), physiologic, and neuro-functional imaging studies in health care providers (HCPs) when practiced over 3 months' time. The investigators define HCPs as any physician, physician trainee, nurse, physician assistant, nurse practitioner or respiratory therapist. HCPs will be screened by a single-item stress scale and Columbia Suicide Severity Rating Scale (CSSRS) to understand their stress level and exclusion criteria respectively. The Global Severity Index of the Brief Symptom Inventory (BSI)-18 Global Severity score will be used as the primary outcome for pre- and post-TM training (baseline, 1 vs. 3 months). In addition, the investigators will evaluate physiological markers of stress and cardiovascular resiliency such as 1) changes (pre/post-treatment) in heart rate variability (HRV) through wearables, 2) Galvanic Skin Response (GSR) - changes in sweat gland activity that result from changes in an emotional state. fMRI will be performed by the Duke Brain Imaging and Analysis Center (BIAC) on a subset of participants to evaluate changes A specifically developed mobile app will aid data collection as well as reminders for providers to aid compliance for meditation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2020
CompletedFirst Posted
Study publicly available on registry
November 17, 2020
CompletedStudy Start
First participant enrolled
November 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 16, 2021
CompletedAugust 23, 2021
May 1, 2021
9 months
November 11, 2020
August 19, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
change in self reported Stress symptoms
Changes in brief symptom inventory as evaluated by BSI 18
Baseline, 1 month, 3 months
Secondary Outcomes (6)
Change in self reported resilience
Baseline, 1 month, 3 months
Change in symptoms of depression
Baseline, 1 month, 3 months
Change in insomnia symptoms
Baseline, 1 month, 3 months
Change in anxiety symptoms
Baseline, 1 month, 3 months
Change in psychological distress
Baseline, 1 month, 3 months
- +1 more secondary outcomes
Study Arms (2)
Transcendental Meditation Intervention Arm
ACTIVE COMPARATORTM, a mind-body intervention that can reduce sympathetic arousal and promote a state of relaxation and calm, will be offered to a randomized group of eligible HCPs ( N=40)providing care during COVID-19 pandemic.
Treatment as usual(TAU) Control Arm
NO INTERVENTIONControl group consists of eligible HCPs who are randomized to control group(N=40) and would not receive any intervention. At the end of 3 month study period, control group participants would be eligible for TM training.
Interventions
TM, a mind-body intervention that can reduce sympathetic arousal and promote a state of relaxation and calm, will be offered to HCPs dealing with COVID-19 pandemic
Eligibility Criteria
You may qualify if:
- HCPs including physicians, trainee physicians, nurses, nurse practitioners, Physician Assistants, and respiratory therapists providing patient care during the COVID-19 pandemic.
- Subjects who have at least a 5% increase from baseline in heart rate after exposure to a personalized stressful script OR at least a 33% increase in skin conductance after exposure to the script
- Willingness to address burnout symptoms by non-pharmacological means
- All subjects must provide Informed Consent prior to enrollment in the study.
- Willingness to wear the provided Apple Watch for the data collection process
You may not qualify if:
- Antipsychotic medications or beta-blockers
- Current suicidal or homicidal ideation (suicidal ideation as screened by C-SSRI survey pre-enrollment)
- Previous instruction in TM
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University health system
Durham, North Carolina, 27710, United States
Related Publications (1)
Joshi SP, Wong AI, Brucker A, Ardito TA, Chow SC, Vaishnavi S, Lee PJ. Efficacy of Transcendental Meditation to Reduce Stress Among Health Care Workers: A Randomized Clinical Trial. JAMA Netw Open. 2022 Sep 1;5(9):e2231917. doi: 10.1001/jamanetworkopen.2022.31917.
PMID: 36121655DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 11, 2020
First Posted
November 17, 2020
Study Start
November 20, 2020
Primary Completion
August 10, 2021
Study Completion
August 16, 2021
Last Updated
August 23, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share